Cancer’s hidden engine: How metabolism could unlock a deadly childhood tumour
Researchers have identified a metabolic vulnerability in fibrolamellar carcinoma, a rare and lethal liver cancer affecting young adults. This discovery suggests that targeting biochemical pathways could be more effective than traditional genetic-focused cancer treatments.
Why it matters
This shift in research focus could lead to new, life-saving therapies for a cancer that is currently resistant to standard chemotherapy.
For more than a century, scientists have sought to understand cancer through the lens of uncontrolled cell division (the genetic mutations that drive relentless growth). Yet an older, often overlooked idea has persisted alongside this framework: that cancer is, at least in part, a disease of metabolism.
The article provides a neutral, scientific report on medical research findings.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in